Protection against Doxorubicin-Induced Cardiac Dysfunction Is Not Maintained Following Prolonged Autophagy Inhibition

Doxorubicin (DOX) is a highly effective chemotherapeutic agent used in the treatment of various cancer types. Nevertheless, it is well known that DOX promotes the development of severe cardiovascular complications. Therefore, investigation into the underlying mechanisms that drive DOX-induced cardio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Montalvo, Ryan N., Doerr, Vivian, Kwon, Oh Sung, Talbert, Erin E., Yoo, Jeung-Ki, Hwang, Moon-Hyon, Nguyen, Branden L., Christou, Demetra D., Kavazis, Andreas N., Smuder, Ashley J.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7662380/
https://ncbi.nlm.nih.gov/pubmed/33143122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21218105
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados